Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

In the world of nuclear medicine, health care professionals face the challenge of safeguarding themselves and their patients ...

Sri Ramakrishna Hospital introduces advanced Tomotherapy Radixact X9 for cancer treatment, praised by Health Minister for ...

A recent study led by Cedars-Sinai researchers reveals that a growing number of older men in the U.S. with intermediate or ...

They found that for men with limited life expectancies and intermediate- and high-risk cancers, conservative management was ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...

A contemporary study finds that overtreatment of prostate cancer is still occurring among older men with limited life expectancy.

Medical physicists at the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) have worked with the ...

Ohio State cancer researchers and surgeons are developing and deploying cutting-edge techniques to help patients.

Radiation therapy has been used to treat cancer since the beginning of the 20th century. This type of treatment continues to be one of the most effective treatments for cancerous (malignant) and ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...

Through partnership with Legion Healthcare Partners, proton therapy system will target tumors without "exit radiation" ...